Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 8263661
Development of new selective estrogen receptor modulators
granted -
US 8263650
Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
granted -
US 8263651
Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to treat conditions mediated by PBR, CB2, and NK2 receptors
granted -
US 8263662
Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products
granted -
US 8263759
Sets of probes and primers for the diagnosis of select cancers
granted -
US 8263747
Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
granted -
US 8263762
Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as A2AR agonists
granted -
US 8263776
Inhibitors of c-Met protein kinase
granted -
US 8263777
Aminopyrazole triazolothiadiazole inhibitor of c-Met protein kinase
granted -
US 8263095
Methods of use for peptides having activities of insulin like growth factor-1
granted -
US 8263677
Removable color gel basecoat for artificial nail coatings and methods therefore
granted -
FR 2972192
COMPOSITION PHARMACEUTIQUE DESTINEE A LA PREVENTION OU AU TRAITEMENT DES CANCERS
granted -
US 8257699
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
granted -
US 8258252
Sustained-release composition and process for producing the same
granted -
US 8258163
Small-molecule agonists for type-2 orexin receptor
granted -
US 8258142
Substituted 8-[6-amino-3-pyridyl]xanthines
granted -
US 8258122
3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives
granted -
US 8257915
Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis
granted -
US 8258263
Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities
granted -
US 8258308
Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors
granted -
US 8258324
Intermediates useful in the preparation of maleimide functionalized polymers
granted -
US 8258257
Claudin-4 binding peptides, compositions and methods of use
granted -
US 8258274
Vaccines containing canine parvovirus genetic variants
granted -
US 8258116
Combination therapy for the treatment of HCV infection
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.